{"id":48375,"date":"2020-10-08T08:42:29","date_gmt":"2020-10-08T06:42:29","guid":{"rendered":"https:\/\/techma.bakertilly.es\/?p=48375"},"modified":"2025-03-12T11:53:55","modified_gmt":"2025-03-12T10:53:55","slug":"capital-cell-sigue-invirtiendo-en-biomedicina-2","status":"publish","type":"post","link":"https:\/\/techma.bakertilly.es\/en\/capital-cell-sigue-invirtiendo-en-biomedicina-2\/","title":{"rendered":"Capital Cell continues to invest in Biomedicine"},"content":{"rendered":"<p>Capital Cell is Europe's first online investment platform specialising in biomedicine. Despite the global coronavirus pandemic, it has raised 4 million euros of investment for 4 companies in the first quarter of 2020. The coronavirus crisis is hitting the global economy hard, especially in our country.&nbsp;<\/p>\n\n\n\n<p>After a tough quarter for the markets, investment funds have opted to bet on biomedical high-tech companies, a sector in full bloom in Spain. This is the case of Cell Capital.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Biotechnology, the only sector to be spared<\/strong>&nbsp;<\/h2>\n\n\n\n<p>According to Capital Cell CEO Daniel Oliver<strong>\"<\/strong>In a context such as the current one, the importance of biotechnology goes from being strategic to being urgent, and it is going to establish itself as one of the most desirable investment sectors\". The investment made by Capital Cell alone would represent more than 12% of the total investment made in the biotechnology sector in Spain in 2018, which amounted to \u20ac98 million according to the Spanish Association of Biotechnology Companies.&nbsp;<\/p>\n\n\n\n<p>No obstante, no s\u00f3lo Espa\u00f1a registra un crecimiento de la inversi\u00f3n en biotecnolog\u00eda. Entre febrero y marzo, el sector biotecnol\u00f3gico ha supuesto la inversi\u00f3n con mayor rentabilidad del \u00edndice NASDAQ estadounidense, mientras la mayor\u00eda de los sectores de inversi\u00f3n, incluyendo el financiero, la energ\u00eda o el inmobiliario, registran desplomes hist\u00f3ricos.\u00a0<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Capital Cell doesn't miss a beat<\/strong>&nbsp;<\/h2>\n\n\n\n\n\n<p>The online investment platform specialising in biomedicine invested four million euros in four companies in the biotech sector in the first quarter of this year, which is 37% more than in the same period last year. It is also more than a third of the total invested last year, as \u20ac11.6m was moved in 2019.&nbsp;<\/p>\n\n\n\n<p>For example, since the start of the Covid-19 crisis confinement, Capital Cell has successfully launched and closed a \u00a4560,000 investment round for Valencian digital diagnostic system company<strong>eKuore<\/strong>. Also other start-ups such as<a href=\"https:\/\/aortyx.com\/\" target=\"_blank\" rel=\"noreferrer noopener\" data-type=\"URL\" data-id=\"https:\/\/aortyx.com\/\">Aortyx<\/a>,<a href=\"https:\/\/www.devicare.com\/es\/\" target=\"_blank\" rel=\"noreferrer noopener\">Devicare<\/a>o<a href=\"https:\/\/www.abilitypharma.com\/\" target=\"_blank\" data-type=\"URL\" data-id=\"https:\/\/www.abilitypharma.com\/\" rel=\"noreferrer noopener\">Ability Pharma<\/a>6 million have been confirmed.\u00a0<\/p>","protected":false},"excerpt":{"rendered":"<p>Capital Cell\u202fes la primera plataforma de inversi\u00f3n online de Europa especializada en biomedicina. A pesar de la pandemia global del coronavirus, ha movido 4 millones de euros de inversi\u00f3n para 4 empresas en el primer trimestre de 2020.&nbsp;La crisis del coronavirus est\u00e1 castigando fuertemente la econom\u00eda global y especialmente, la de nuestro pa\u00eds.\u202f&nbsp; Tras un [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":48376,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[1751],"tags":[],"sectores":[],"tipo-contenido":[2260],"class_list":["post-48375","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-adquisiciones-mas-relevantes","tipo-contenido-noticias"],"acf":[],"_links":{"self":[{"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/posts\/48375","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/comments?post=48375"}],"version-history":[{"count":0,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/posts\/48375\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/media\/48376"}],"wp:attachment":[{"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/media?parent=48375"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/categories?post=48375"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/tags?post=48375"},{"taxonomy":"sectores","embeddable":true,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/sectores?post=48375"},{"taxonomy":"tipo-contenido","embeddable":true,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/tipo-contenido?post=48375"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}